Nitroglycerine exerts beneficial effects in variant angina primarily by:
**Core Concept**
Nitroglycerine is a nitric oxide donor that relaxes vascular smooth muscle by activating guanylyl cyclase, leading to an increase in cyclic guanosine monophosphate (cGMP) levels. This results in vasodilation of coronary arteries and a decrease in myocardial oxygen demand.
**Why the Correct Answer is Right**
Nitroglycerine donates nitric oxide, which activates soluble guanylyl cyclase in vascular smooth muscle cells. This enzyme catalyzes the conversion of guanosine triphosphate (GTP) to cGMP, leading to the relaxation of vascular smooth muscle and vasodilation. In variant angina, also known as Prinzmetal's angina, vasospasm of coronary arteries is the primary cause of chest pain. Nitroglycerine's ability to cause vasodilation helps to relieve this vasospasm and improve blood flow to the myocardium.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is not relevant to the mechanism of action of nitroglycerine in variant angina.
**Option B:** While beta-blockers can help to reduce heart rate and myocardial oxygen demand, they do not directly address the vasospasm seen in variant angina.
**Option C:** Calcium channel blockers can help to relax vascular smooth muscle and prevent vasospasm, but they are not the primary mechanism by which nitroglycerine exerts its beneficial effects in variant angina.
**Clinical Pearl / High-Yield Fact**
Nitroglycerine is a useful treatment for variant angina because it can help to relieve vasospasm and improve blood flow to the myocardium. However, it should be used cautiously in patients with hypotension or heart failure, as it can further decrease blood pressure.
**Correct Answer: A**